Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-22 Disposition | 2024-08-22 09:08 am | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 2,162,155 | $0 | 0 (Direct) | View |
| 2024-04-21 Tax Withholding | 2024-04-23 5:47 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 43,638 | $0.25 | 416,288 (Direct) | View |
| 2024-04-21 Exercise | 2024-04-23 5:47 pm | 2024-04-21 N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 81,521 | $0 | 416,288 (Direct) | View |
| 2024-02-04 Tax Withholding | 2024-02-06 7:01 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 150,367 | $0.27 | 2,124,272 (Direct) | View |
| 2024-02-06 Option Award | 2024-02-06 7:01 pm | N/A 2031-02-06 | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 1,387,700 | $0 | 2,124,272 (Direct) | View |
| 2024-02-04 Exercise | 2024-02-06 7:01 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 561,818 | $0 | 2,124,272 (Direct) | View |
| 2023-07-01 Tax Withholding | 2023-07-05 5:30 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 6,975 | $0.51 | 247,863 (Direct) | View |
| 2023-07-01 Exercise | 2023-07-05 5:30 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 33,332 | $0 | 247,863 (Direct) | View |
| 2023-04-21 Option Award | 2023-04-25 6:35 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 81,521 | $0 | 81,521 (Direct) | View |
| 2023-02-03 Option Award | 2023-02-07 6:00 pm | N/A 2030-02-03 | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 700,000 | $0 | 1,227,246 (Direct) | View |
| 2023-02-04 Tax Withholding | 2023-02-07 6:00 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 103,998 | $0.75 | 1,227,246 (Direct) | View |
| 2023-02-04 Exercise | 2023-02-07 6:00 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 497,024 | $0 | 1,227,246 (Direct) | View |
| 2022-07-01 Tax Withholding | 2022-07-05 5:30 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 7,015 | $0.38 | 110,324 (Direct) | View |
| 2022-07-01 Exercise | 2022-07-05 5:30 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 33,334 | $0 | 110,324 (Direct) | View |
| 2022-02-04 Tax Withholding | 2022-02-07 5:20 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 26,711 | $0.8 | 844,092 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-07 5:20 pm | N/A 2029-02-04 | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 681,270 | $0 | 844,092 (Direct) | View |
| 2022-02-04 Exercise | 2022-02-07 5:20 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 197,216 | $0 | 844,092 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-02 7:14 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 33,334 | $0 | 45,442 (Direct) | View |
| 2021-07-01 Tax Withholding | 2021-07-02 7:14 pm | N/A N/A | ASENSUS SURGICAL INC. | ASXC | Shameze Rampertab EVP, Chief Financial Officer | 4,558 | $2.93 | 45,442 (Direct) | View |
| 2021-02-08 Option Award | 2021-02-08 8:50 pm | N/A 2028-02-08 | TRANSENTERIX INC. | TRXC | Shameze Rampertab EVP, Chief Financial Officer | 250,502 | $0 | 250,502 (Direct) | View |
| 2020-08-24 Option Award | 2020-08-25 7:06 pm | N/A 2027-08-24 | TRANSENTERIX INC. | TRXC | Shameze Rampertab EVP, Chief Financial Officer | 200,000 | $0 | 200,000 (Direct) | View |
Ownership | 2020-08-25 7:04 pm | N/A N/A | TRANSENTERIX INC. | TRXC | Shameze Rampertab EVP, Chief Financial Officer | 0 | $0 | 0 (Direct) | View |
| 2020-03-13 Option Award | 2020-03-17 4:13 pm | N/A 2025-03-13 | Zomedica Pharmaceuticals Corp. | ZOM | Shameze Rampertab Interim CEO and CFO | 900,000 | $0 | 900,000 (Direct) | View |